Investigating the 3D structure of proteins related to SARS-CoV-2 and other infectious diseases
Centers for Research on Structural Biology of Infectious Diseases: SARS-CoV-2
This study is looking at the tiny structures of proteins related to COVID-19 and other infectious diseases to help find better treatments and vaccines, which could ultimately benefit patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11160417 on NIH RePORTER |
What this research studies
This research focuses on using advanced structural biology techniques to determine the three-dimensional atomic structures of proteins associated with SARS-CoV-2 and other emerging infectious diseases. By understanding these structures, researchers aim to uncover the molecular functions of these proteins, which could lead to new insights in treating infectious diseases. The project involves high-throughput methods to analyze these proteins, which are critical for developing effective therapies and vaccines. Patients may benefit from the findings as they could lead to improved treatments for COVID-19 and similar diseases.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals affected by COVID-19 or those at risk of emerging infectious diseases.
Not a fit: Patients with non-infectious diseases or those not affected by COVID-19 or related pathogens may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new treatments and vaccines for COVID-19 and other infectious diseases.
How similar studies have performed: Other research has shown success in using structural biology approaches to understand infectious diseases, indicating that this methodology is both promising and tested.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Satchell, Karla — Northwestern University at Chicago
- Study coordinator: Satchell, Karla
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.